Skip to main content
C

Concord Drugs Limited — Investor Relations & Filings

Ticker · 538965 ISIN · INE858L01010 LEI · 98450014CO7460A4A188 BSE.NS Manufacturing
Filings indexed 0 across all filing types
Latest filing no filings yet
Country IN India
Listing BSE.NS 538965

About Concord Drugs Limited

https://concorddrugs.in/

Concord Drugs Limited specializes in the development, manufacturing, and marketing of pharmaceutical formulations across various therapeutic segments. The company’s product range encompasses finished dosage forms, including tablets, capsules, liquid orals, and dry syrups. Key therapeutic areas of focus include anti-infectives, analgesics, anti-inflammatory agents, and gastrointestinal medications. In addition to marketing its own branded products, the company provides contract manufacturing and formulation development services to global and domestic partners. Its operations are supported by manufacturing facilities designed to comply with international quality standards, ensuring the production of safe and effective medicinal products for diverse healthcare needs.

Recent filings

No filings indexed yet

We are still gathering filings for Concord Drugs Limited. .

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.